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Maternal imprinting on cognition 
markers of wild type and transgenic 
Alzheimer’s disease model mice
Marta Zamarbide1, Francisco J. Gil-Bea1, Paul Bannenberg1, Eva Martínez-Pinilla1,  
Juan Sandoval5, Rafael Franco2,3 & Alberto Pérez-Mediavilla1,4
The risk of suffering from Alzheimer’s disease (AD) is higher in individuals from AD-affected mothers. 
The purpose of this investigation was to study whether maternal transmission might produce AD-
related alterations in progenies of mice that do not have any genotypic alteration. We used cognitively-
intact mothers harbouring in heterozygosity the transgene for overexpressing the Swedish double 
mutant version of the human amyloid precursor protein (hAβPPswe). The phenotype of the offspring 
with or without the transgene resulting from crossing young Tg2576 females with wild-type males were 
compared with those of the offspring resulting from crossing wild-type females with Tg2576 males. 
The hAβPPswe-bearing offspring from Tg2576 mothers showed an aggravated AD-like phenotype. 
Remarkably, cognitive, immunohistochemical and some biochemical features displayed by Tg2576 
heterozygous mice were also found in wild-type animals generated from Tg2576 females. This suggests 
the existence of a maternal imprinting in the wild-type offspring that confers a greater facility to launch 
an AD-like neurodegenerative cascade. Such progeny, lacking any mutant amyloid precursor protein, 
constitutes a novel model to study maternal transmission of AD and, even more important, to discover 
early risk markers that predispose to the development of AD.
Two different types of Alzheimer’s disease (AD), which is the most common cause of dementia, are identified on 
the basis of pathologic, genetic and molecular evidence. The early-onset Alzheimer’s disease (EOAD) is due to 
mutations of human amyloid-β precursor protein (hAβPP) or presenilin genes. Late-onset Alzheimer’s disease 
(LOAD), the most common form of the disease, is not linked to specific gene alterations and its aetiology is 
caused by a complex interaction between genetic and life-style factors. After age, the second most important risk 
factor for LOAD is having a parent with the disease1,2. In particular, it is assumed that maternal inheritance con-
tributes more than parental inheritance to the risk of suffering AD. Therefore, different studies with LOAD cases 
have consistently found that maternal AD history is 2–3 times more abundant than the paternal one3–6. Honea 
et al. described a correlation between maternal family history of AD (MH) and lower grey matter volume in AD 
vulnerable brain regions7. Maternal family history in LOAD has been also related with a reduced activity of the 
key mitochondrial enzyme, cytochrome oxidase8. Moreover, mutations in the X chromosome and mitochondrial 
DNA are also behind the consequences of maternal inheritance9. Less studied is whether maternal transmission 
of non-(nuclear)genetic components constitutes a risk factor in vertical AD transmission.
High blood pressure, diabetes and hypercholesterolemia are among the variety of risk factors that have been 
linked to LOAD. A common factor in the disease is oxidative stress, whose reduction by antioxidants is con-
sidered promising to combat AD. Oxidative stress markers in the cerebrospinal fluid of AD patients10 reflect 
pro-oxidant conditions and alterations in cerebral structures. In fact, the overall data point to oxidative damage 
as an early event in AD and to a relevant role of mitochondria in AD pathogenesis11. Oxidative modified nucleic 
acids have been found in AD brains12 and increased lipid peroxidation is already observable in the early stages of 
the disease13. Acrolein, is a product of lipid peroxidation that causes oxidative stress in brain mitochondria14,15, is 
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upregulated in AD brains16 and is present in more than half of neurofibrillary tangles17. The best studied EOAD 
-associated mutation is the Swedish double mutation in the hAβPP gene (hAβPPswe)18. This mutation has been 
instrumental to develop the Tg2576 transgenic mouse model, which overexpresses hAβPPswe. Cognitive alter-
ations in the Tg2576 mouse appear from nine months of age and, interestingly, it correlates with marked altera-
tions in the level of mitochondrial proteins19.
The aim of this work was to assess the risk of displaying cognitive deficits associated to be offspring of Tg2576 
females. From behavioural and biochemical assays, we demonstrate that wild type progeny from Tg2576 females 
have some of the most characteristic features of AD. The generated animal models, WT and heterozygous Tg2576 
animals with maternal imprinting (WTM and Tg2576M), show promise to understand AD maternal transmission 
and to discover early risk markers that predispose to develop AD.
Results
Behavioral impairment in WTM mice. The cognitive status of the different animal groups, consisting of 
WT and Tg2576 offspring from wild type (non-hAβPPswe) or hAβPPswe-overexpressing mothers, was assessed 
at four months using a conditioned fear protocol. The choice of this age is based on previous data showing impair-
ment in this test in four-month-old Tg2576 mice20. WTM animals exhibited impaired fear conditioned memory 
as they showed lower freezing times than WT mice (F3,56 = 7.6; p < 0.05 Fig. 1a).
Likewise, we evaluated the spatial memory of the animals by the Morris Water Maze test (MWM). The test 
was performed at an age of 8 months, when it has been already demonstrated that the Tg2576 mice (coming from 
a WT female and a Tg2576 male) do not yet display deficits in spatial memory. Figure 1b indicates that all animals 
could learn in the training sessions. Escape latencies were progressively reduced in all groups, with differences 
between day 1 and day 3. Escape latencies to hidden platform of both Tg2576M and WTM mice were significantly 
longer than those of their corresponding controls (WT and Tg2576, F3,348 = 10.73; p < 0,01) (Fig. 1c). It is note-
worthy that the performance of WTM mice was significantly worse than that of WT animals. Therefore, maternal 
transmission resulted in affected cognitive function in the WTM group and accelerated the cognitive decline in 
the Tg2576M mice.
WTM animals display some AD histopathological features. To identify mechanisms underlying the 
poor task performance in offspring from AD-affected mothers, a variety of biochemical parameters were ana-
lysed in cortical and hippocampal samples, including immunohistochemistry studies to detect hAβPP and pTau 
in hippocampal slices. As the pTau/Tau balance is a key factor in AD pathology, the relative levels of pTau and of 
proteins involved in Tau phosphorylation were assessed by immunoblotting in hippocampal samples. The pTau/
Tau ratio was not only elevated in Tg2576 and Tg2576M but in WTM animals (F1,12 = 12.08; p < 0.01) (Fig. 2a). 
Figure 1. Fear conditioning and MWM tests in the four animal groups (WT, WTM, Tg2576 and Tg2576M). The 
results are expressed as the mean ± SEM (n = 10–12). Statistical significance was analysed by two-way ANOVA 
with Tukey’s post-hoc test. Panel a, percentage of freezing in the fear conditioning test performed in 4-month-
old animals. Panels b-c, escape latency of 8-month-old mice in the visible (b) and hidden-platform (c) of the 
MWM. *p < 0.05, **p < 0.01 respect to WT; ##p < 0.01 respect to Tg2576; $p < 0.05 day 1 respect to day 8.
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The fact that the two-way ANOVA analysis shows no interaction between transgenic and maternal imprinting 
strongly suggests that the increase in pTau in the WTM mice was due to the maternal inheritance. The results 
obtained when Akt phosphorylation (Ser473), was analysed were similar. Akt phosphorylation (Ser473), which is 
a relevant parameter in the regulation of pTau levels21,22, was decreased in Tg2576M versus Tg2576 (F1,12 = 23.90; 
p < 0.001) and in WTM versus WT (F1,12 = 48.72; p < 0.01); the statistical analysis shows that the effect was due to 
maternal inheritance and not to being transgenic. It should be noted that Akt phosphorylation was significantly 
lower in the Tg2576M than in any other group (Fig. 2b). The analysis of Tyr216 phosphorylation, which acti-
vates GSK3β23 and leads to aberrant Tau phosphorylation shows significant interaction (F3,12 = 16.56; p < 0.001) 
between the transgenic and maternal inheritance factors. The activation of GSK3β is enhanced in transgenic 
animals but at higher levels in Tg2576 than in Tg2576M (F1,12 = 65.10; p < 0.01) (Fig. 2c). Moreover, phosphoryl-
ation levels of βcatenin, which is targeted by GSK3β for phosphorylation and subsequent degradation24,25, were 
significantly enhanced in the two groups of transgenic animals but without any effect due to maternal transmis-
sion (F1,12 = 16.677; p < 0.05) (Fig. 2d). In line with the immunoblotting results displayed in Fig. 2a, pTau immu-
nohistochemistry showed that both transgenic and WTM animals exhibited pTau-immunoreactive neurons in 
hippocampus and entorhinal cortex. Images of AT8 immunoreactivity are shown in Fig. 3a–h and quantification 
in Fig. 3i. The results show differences in AT8 due to transgenicity (F1,8 = 15.54; p < 0.01) and a tendency when 
maternal transmission was considered.
Finally, the impact of maternal transmission on one of the main hallmarks of the AD pathology, AβPP pro-
cessing, was assessed by immunohistochemistry (Fig. 4a–l) distinguishing major “mature” from minor “diffuse” 
plaques, immunoblotting (Fig. 5a–d) and BACE1 activity (Fig. 5e). The use of the 4G8 antibody, which detects 
a common human/mouse amyloid-β (Aβ) sequence in the AβPP, confirmed that maternal transmission could 
give rise to aggregated forms of mouse Aβ both in the hippocampus and entorhinal cortex of WTM and Tg2576M. 
When major plaques were addressed we found an increase due to the transgenic factor and not to the maternal 
inheritance (F1,8 = 10.88; p < 0.05) (Fig. 4m). In the case of minor plaques, maternal inheritance had a clear effect 
in transgenic animals and, although not significant, a tendency of higher expression in WTM versus WT animals 
was found (Fig. 4n).
These results show that maternal transmission of non-genetic material accelerated plaque deposition in 
Tg2576M brain and, strikingly, provoked the aggregation of the murine amyloid on WTM mice. Immunoblotting 
Figure 2. Levels of Tau, pTau and of proteins involved in regulating Tau phosphorylation. Results from Western 
blot of hippocampal membrane extracts from WT, WTM, Tg2576 and Tg2576M mice are displayed. We show 
representative lanes from representative blots (full-length blots are presented in Supplementary Figure 1) 
and the quantification of immunolabeled bands. The results (fold over control –WT-) are expressed as the 
mean ± SEM (n = 4). Statistical significance was analysed by two-way ANOVA with Tukey’s post-hoc test (a) 
pTau versus Tau. (b) pAkt versus actin. (c) pGSK3β (Tyr216) versus GSK3β. (d) pβcatenin versus β-catenin. 
*p < 0.05, **p < 0.005, ***p < 0.0001.
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using the CT19 antibody, which detects the C-terminal fragment of both human and murine AβPP, confirmed 
that the level of AβPP expression was not affected by maternal transmission in either WT or transgenic animals 
(Fig. 5a,b). Statistical analysis showed that there are no differences in AβPP levels between WT and WTM and 
neither between Tg2576 and Tg2576M. Production of C83 peptide, which results from the non-amyloidogenic 
Figure 3. Immunohistochemistry using the AT8 antibody in hippocampal (a,c,e,g) and entorhinal cortex 
(b,d,f,h) sections from WT (a,b), WTM (c,d), Tg2576 (e,f) and Tg2576M (g,h) mice. Scale bars: 50 µm. 
Quantification of AT8 staining per hippocampal section (i). Data are the mean ± SEM of six different areas 
covering the entire hippocampus from two sections on the anatomically comparable plane for each animal 
(n = 3). Statistical significance was analysed by two-way ANOVA with Tukey’s post-hoc test. **p < 0.005.
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processing pathway, was significantly decreased in WTM respect to WT (F1,12 = 10.81; p < 0.05); a similar trend 
without statistical significance was observed in Tg2576M versus Tg2576 (Fig. 5c). Production of C99 peptide pre-
cursor of Aβ, was significantly higher in the transgenic mice when compared to WT or WTM mice (F1,12 = 10.01; 
Figure 4. Immunohistochemistry using the 4G8 antibody in sections from WT (a,b), WTM (c–f), Tg2576 (g,h) 
and Tg2576M (i–l) mice. Panels a, c, g and i are from hippocampus; panels b, e, h, and k are from entorhinal 
cortex. Animals used were 8-month-old in panels a-f and i-j and 15-months-old in panels g-h and k-l. Scale 
bars: 50 μm. Aβ staining was quantified as number of major and minor plaques per hippocampal section (m-n).  
Data are the mean ± SEM. Six different areas covering the entire hippocampus from two sections on the 
anatomically comparable plane for each animal were analyzed (n = 3). Statistical significance was analysed by 
two-way ANOVA with Tukey’s post-hoc test. *p < 0.05.
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p < 0.05), and no significant differences were found between Tg2576 and Tg2576M (Fig. 5d). Due to the tendency 
of increased C99 expression found by maternal transmission in both WT and transgenic animals, we measured 
BACE-1 activity. The results (Fig. 5e) were very similar to those obtained for C99 expression, i.e. increase due to 
transgenicity (F1,12 = 11.81; p < 0.05) and no significant changes but a tendency due to maternal transmission.
Considering maternal inheritance, the results showed a similar non-significant tendency as in the C99 expres-
sion, while the activity was significantly higher in transgenic versus non-transgenic animals.
Synaptic plasticity impairment in the offspring of Tg2576 mothers. Ionotropic AMPA gluta-
mate receptors (GluR) are composed of A1 and A2 subunits whose phosphorylation status is altered in AD26. 
Whereas total levels of A2/3 subunits were not affected (Supplementary Figure 4A), the degree of GluA1 phos-
phorylation was significantly reduced in all groups when compared with WT animals (F1,12 = 10.46; p < 0.05) 
(Fig. 6a). The phosphorylated and active state of CaMKII, which is key for long-term potentiation and synaptic 
plasticity27, was also reduced in these groups (Fig. 6b). Interestingly, pCaMKII levels were significantly decreased 
in Tg2576M (compared to Tg2576) (F1,12 = 16.21; p < 0.05). The level of PSD95, a marker for post-synaptic den-
sities, was rather similar in the four groups (Supplementary Figure 4b). These findings suggest the possibility of 
maternal-transmission-related impairment of synaptic function in the cortical tissue.
Microtubules and actin microfilaments are stabilized during neuronal morphogenesis and are critical for intra-
cellular transport and for overall neuronal and spine architecture and dynamics28,29. The level of three cytoskeletal 
protein markers was quantitated in membranes from cortex. Activity-regulated cytoskeleton-associated protein 
(Arc) is required for memory consolidation through regulation of F-actin expansion thus playing critical roles in 
synaptic plasticity and memory storage30. Arc levels analysed by a two-way ANOVA showed a significant decrease 
(F1,12 = 18.98; p < 0.01) in the transgenic versus WT mice. Also, a post-hoc test revealed in WT mice a marked 
decrease in Arc expression due to the maternal transmission (F1,12 = 23.69; p < 0.001) (Fig. 7a). Cofilin is involved 
Figure 5. Proteolytic processing of AβPP. (a) Representative Western blot of full-length AβPP and AβPP 
carboxy-terminal fragments, C99 and C83, in total protein cortical extracts. Full-length blots are presented in 
Supplementary Figure 2. Quantification of immunolabeled bands for AβPP (b), C83 (c) and C99 (d). The results 
(fold over control –WT-) are expressed as the mean ± SEM (n = 4). (e) BACE-1 activity. The activity of BACE-1 
was determined as described in Methods. Data are the mean ± SEM (n = 4). Statistical significance was analysed 
by two-way ANOVA with Tukey’s post-hoc test. *p < 0.05, ***p < 0.001.
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in nucleation, polymerization/depolymerization and reorganization of actin. As neurodegenerative stimuli 
leads to activation of cofilin by dephosphorylation31 the p-cofilin/actin ratio was quantified. The results show a 
decrease in p-cofilin in transgenic animals. The two-way ANOVA analysis also demonstrated a significant effect 
(F3,12 = 23.30; p < 0.001) in the transgenic mice, regardless of which progenitor carried the transgene (Fig. 7b); the 
post-hoc test revealed significantly lower levels of p-cofilin in Tg2576M mice when compared to Tg2576 animals 
(F1,12 = 605.1; p < 0.001). Together with Tau, the microtubule-associated protein 2 (MAP2) is one of the main 
microtubule-associated protein in mammalian nerve cells. Interestingly, this protein only decreased significantly 
in Tg2576M although a similar but no statistically significant tendency was found in WTM and Tg2576 animals 
(Fig. 7c).
Mitochondrial VDAC-1 and HXKI levels were affected by maternal transmission. The two 
mitochondrial proteins whose levels were quantitated in hippocampal extracts were VDAC-1 (Fig. 8a), a 
voltage-dependent anion channel differentially expressed in the brain of AD mouse models32, and hexokinase 
type 1 (HXKI) (Fig. 8b), which is differentially expressed in AD patients33 and Tg2576 mice32. Whereas the level 
of HXKI was reduced in transgenic animals with no effect of maternal transmission (F1,12 = 8.64; p < 0.05), the 
level of VDAC-1 was increased in the transgenic group if compared with the non-transgenic one (F1,12 = 8.96; 
p < 0.05). It should be noted that the level of VDAC-1 in WTM was also increased when compared to WT animals.
Discussion
In order to study the effect of maternal transmission in AD we designed a particular way of generating a 
Tg2576-derived novel mouse model of AD. Usually the offspring of the current model is obtained from crossing 
healthy WT females with hAβPPswe overexpressing males. However, no studies of offspring bred from healthy 
WT males and hAβPPswe overexpressing females have been reported. The new model and the present findings 
reveal that vertical transmission from hAβPPswe-overexpressing mothers, at an age that do not display any cog-
nitive impairment, results in accelerated cognitive deficits in Tg2576 transgenic animals. Remarkably, acquisition 
of characters from Tg2576 females leads to spatial memory impairment and pathological alterations in animals 
that do not express hAβPPswe, i.e. in the WTM group.
Figure 6. Effect of maternal transmission of non-genetic material on synaptic plasticity markers. The levels 
of synaptic markers in total protein cortical preparations from WT, WTM, Tg2576 and Tg2576M mice were 
analysed by Western blot. We show representative blots (full-length blots are presented in Supplementary 
Figure 3) and the quantification of immunolabeled bands. The results (fold over control –WT-) are expressed 
as the mean ± SEM (n = 4). Statistical significance was analysed by two-way ANOVA with Tukey’s post-hoc test. 
(a) pGluA1 AMPA receptor subunit  versus actin. (b) Phosphorylated CaMK II versus total CaMK II. *p < 0.05, 
**p < 0.005, ***p < 0.0001 respect to WT; #p < 0.05 respect to Tg2576.
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8SCIENtIFIC REPORTS |  (2018) 8:6434  | DOI:10.1038/s41598-018-24710-7
Phosphorylation of Tau is one of the major pathological features in AD brains that also appear in the Tg2576 
mouse. 8-month-old Tg2576 mice, which do not yet exhibit cognition deficits, already showed Tau pathology in 
terms of elevated levels of pTau and elevated levels of active Tau kinases. Furthermore, Aβ pathology in terms of 
amyloid accumulation was found in 8-month-old Tg2576M but not in Tg2576 animals. The decrease in cytoskele-
tal or plasticity-related proteins is evident in young Tg2576 mice before the appearance of deficits in spatial mem-
ory. Compared to age-matched Tg2576 animals, 8-month-old Tg2576M had similar or exacerbated alterations in 
the 15 markers analysed. In the hippocampus or cortex from both Tg2576 and Tg2576M animals, Tau was heavily 
phosphorylated due to enhanced activity of some kinases, neural plasticity markers were down-regulated and the 
levels of mitochondrial VDAC-1 and HXKI were altered. Collectively, our results show that the early cognitive 
decline in Tg2576M shares the underlying molecular determinants that are relevant for the human disease.
One remarkable finding of the present work was that mice lacking the hAβPPswe transgene but bred from 
young Tg2576 mothers (WTM) displayed biochemical traits found in aged Tg2576 and Tg2576M animals. In this 
sense, phosphorylation of Tau was enhanced and CaMKII, Arc, Akt and AMPA GluR1 levels were reduced.
The occurrence of Aβ aggregates was confirmed using the anti-Aβ 17–24 (4G8) monoclonal antibody that 
reacts within the amyloid domain, as well as with the precursor forms of both human and mouse AβPP. This 
murine Aβ accumulation in WTM mice is a striking result of this work as current murine models of amyloidosis 
are based on human AβPP overexpression. Nevertheless, cerebral murine Aβ accumulation has been reported in 
other non-transgenic mouse lines such the senescence-accelerated mouse (SAMP8)34 and the murine model of 
age-related macular degeneration35. Accumulation of amyloid into aggregates in the WTM mouse makes it a good 
model to better understand the mechanisms of APP processing and Aβ aggregation.
Cognitive deficits and biochemical alterations in WTM animals resemble those in Tg2576 mice, thus likely 
pointing to a common pathological mechanism but, of course, with differential onset. Damaged mitochondria 
are likely present in the ovum of hAβPPswe females. A proteomics study performed in the hippocampus of the 
Tg2576 showed that a large percentage of mitochondrial proteins were deregulated in 7-month-old Tg2576 mice; 
among them VDAC-1 and HXKI32. Deregulation of VDAC-1 and a clear trend towards reduced HXKI levels in 
WTM animals suggest that ovum mitochondria may have similar alterations than hippocampal mitochondria in 
Figure 7. Effect of maternal transmission of non-genetic material on neuronal cytoskeletal markers. The levels 
of cytoskeleton markers in total protein cortical preparations WT, WTM, Tg2576 and Tg2576M mice were 
analysed by Western blot. Representative blot and quantification of immunolabeled bands for (a) Arc versus 
actin, (b) pCofilin versus actin and (c) MAP2 versus actin. Full-length blots are presented in Supplementary 
Figure 5. The results (fold over control –WT-) are expressed as the mean ± SEM (n = 4). Statistical significance 
was analysed by two-way ANOVA with Tukey’s post-hoc test. *p < 0.05, **p < 0.005, ***p < 0.0001 respect to 
WT; ###p < 0.0001 respect to Tg2576.
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females overexpressing the hAβPPswe. Tg2576 animals seem to be able to cope with the extra-metabolic needs 
due to ER stress. Also, an adaptive variation in the level of mitochondrial proteins seems to be sufficient to keep 
hippocampal neurons alive32. Interestingly, RNA-based silencing of hAβPP, Tau, and VDAC-1 genes in human 
neuroblastoma cells results in improved mitochondrial function36. Also relevant is the possibility of mitochon-
drial import and degradation of Aβ37–39. ER signal peptide of APP may alternatively target the protein to the 
mitochondria and this alternative targeting depends on the structure of the nascent chain. In conditions of com-
promised ER import due to unstructured polypeptides hAβPP increases traffic to mitochondria38. Thus, it seems 
likely that stress caused by overexpression of hAβPPswe in ovum cells is transmitted to offspring cells and results 
in accelerated phenotype in Tg2576M and AD-like phenotype in WTM mice.
Epigenetic changes including genomic imprinting may affect LOAD risk. There are more than one hun-
dred known imprinted genes and most of them are expressed in human brain40. In addition to this, maternally 
expressed imprinted genes in mice are expressed in cerebral cortex/hippocampal regions associated with memory 
tasks41. Thus, it is possible that silencing of imprinting of maternal alleles disrupts the cognitive function of the 
brain, and be a factor in neurodegenerative disorders like AD. Future studies may help to assess the relevance of 
epigenetics modification in AD-related maternal inheritance. In particular, epigenetic modification in mitochon-
drial DNA, which is only transmitted by mothers, should be taken into account. As recently reviewed42 this field 
is lacking way behind epigenetics related to nuclear DNA and more studies are, in our opinion, needed to be able 
to identify reliable “mitochondrial” epigenetic markers and how they may be affected in different physiological 
or pathological situations.
Methods
Generation of the mouse model. Unless otherwise stated the experiments were performed in 8-month-
old mice. The genotypes of the two parental mice used were: wild type (WT) and Tg2576, which is a transgenic 
line that expresses in heterozygosity the human 695-aa isoform of the hAβPP containing the Swedish double 
mutation [(APP695)Lys670 → Asn, Met671 → Leu] driven by a hamster prion promoter43. WT and Tg2576 ani-
mals were generated by breeding a WT female (B6SJL genetic background) with a Tg2576 male. The homozy-
gous Tg2576 transgene is lethal so all the Tg2576 animals used for the experiments were heterozygous. The 
so-called WTM and Tg2576M mice were generated by breeding a 8-month old Tg2576 female with a WT male 
(B6SJL genetic background). At 8 months of age Tg2576 females display neither amyloid plaques nor cognitive 
Figure 8. Levels of selected mitochondrial proteins in hippocampal extracts from WT, WTM, Tg2576 and 
Tg2576M mice. We show a representative blot and the quantification of immunolabeled bands: VDAC-1 versus 
actin (a) and hexokinase type 1 (HXKI) versus actin (b). Full-length blots are presented in Supplementary 
Figure 6. The results (fold over control –WT-) are expressed as the mean ± SEM (n = 4). Statistical significance 
was analysed by two-way ANOVA with Tukey’s post-hoc test. *p < 0.05 respect to WT.
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impairment in the Morris Water Maze (MWM) test. Overall, 44 animals distributed in four groups of animals 
were studied: WT, WTM, Tg2576 and Tg2576M.
The animals were maintained in positive pressure-ventilated racks at 25 ± 1 °C with a 12 h light/dark cycle, fed 
ad libitum with a standard rodent pellet diet (Global Diet 2014; Harlan Laboratories, Indianapolis, USA) and free 
access to filtered and UV-irradiated water. All animal care and experimental procedures were in accordance with 
European and Spanish regulations (86/609/CEE; RD1201/2005) and were approved by the Ethical Committee 
of the University of Navarra (no. 018/05). Behavioural studies were carried out during light time (from 9 am to 
2 pm).
Morris water maze test. 8-month-old animals from WTM (n = 12), Tg2576 (n = 10), Tg2576M (n = 10) and 
WT (n = 12) groups were subjected to a hippocampus-dependent learning task in the MWM test44. The water 
maze was a circular tank (diameter 1.2 m) filled with water at 20 °C and made opaque by the addition of non-toxic 
white paint. Mice underwent visible-platform training for three consecutive days (6 trials/day), and were allowed 
to swim to a platform (10-cm diameter) located above the water level in the same position over the trials. No 
distal visible cues were present during this phase. Hidden-platform training was conducted over 8 consecutive 
days (4 trials/day). Mice had 60 s to find a hidden platform submerged 1 cm beneath the surface of the water and 
invisible to the mice while swimming. Several large visual cues were placed in the room to guide the mice to the 
hidden platform. In both visible- and hidden-platform versions of this test, mice were placed randomly in dif-
ferent locations each trial, facing towards the wall of the pool in order to eliminate the potentially confounding 
contribution of spatial cues. Mice failing to reach the platform were guided there and their position was held for 
15 s until they were returned to their home cage. All trials were monitored by a camera located above the centre 
of the pool and connected to a SMART-LD program (Panlab S.L., Barcelona, Spain) for subsequent analysis of 
escape latencies, swimming speed and path length. Mice that were unable to reach the visible-platform or mice 
exhibiting thigmotactic patterns or persistent floating were excluded from data analyses.
Contextual fear conditioning. The behavioral procedure involved three phases: habituation, training and 
testing. Four-month-old mice from WTM (n = 15), Tg2576 (n = 16), Tg2576M (n = 10) and WT (n = 18) groups 
were habituated to the conditioning box (context) for 5 min with no stimuli presented. The context consisted in 
a sound-proof box with white walls, light and a background noise produced by a fan. Twenty‐four hours later 
(training phase) mice were placed in the same context and allowed to explore for 2 min. Afterwards, a foot shock 
(0.3 mA) unconditioned stimulus was administered (2 s) and 30 s after mice were returned to their home cage. 
24 h later mice were placed back in the conditioning chamber and allowed to explore the context for 3 min, during 
which freezing time was recorded (contextual long‐term memory). Freezing behavior was defined as an absence 
of cage displacement. Freezing scores were expressed as percentages of total freezing time. The conditioning pro-
cedure was carried out in a StartFear system (Panlab S.L., Barcelona, Spain) that allows movement recording by a 
high‐sensitivity Weight Transducer system and data analysis by the built-in FREEZING and STARTLE software.
Tissue processing for immunohistochemistry. Under xylazine/ketamine anaesthesia, animals were 
perfused transcardially with saline and 4% paraformaldehyde in phosphate buffered saline (PBS). After perfu-
sion, brains were removed, post-fixed in the same fixative solution for 1 h at room temperature and cryoprotected 
in 30% sucrose solution in PBS overnight at 4 °C. Microtome sections (30 µm-thick) were coronally cut through 
the entire hippocampus, collected free-floating and stored in 30% ethylene glycol, 30% glycerol, and 0.1 M PBS at 
−20 °C until processed.
Immunohistochemistry. Nine free floating tissue sections comprising the hippocampal formation of 
three animals per group were processed for immunohistochemistry. Brain sections were washed (3 × 10 min) 
with a solution buffer containing PBS 0.125 M (pH 7.4), 0.5% Triton X-100 and 0.1% BSA. After washing, sec-
tions were treated with methanol and H2O2 to inhibit endogenous peroxidase activity and incubated in 70% 
formic acid for 7 min to expose the epitope. Sections were incubated overnight with primary antibody 4G8 (anti 
18–22 Aβ amino acids; 1:500, Chemicon International, Billerica, MA, USA) or anti-pTau primary antibody AT8 
(1:1000, Thermo Fisher Scientific, Rockford, USA) at 4 °C. After washing, sections were incubated sequentially 
with biotinylated goat anti-mouse secondary antibody (1:500, DakoCytomation, Glostrup, Denmark) for 2 h, an 
ABC kit immunoassay detection system (Vector Labs, Burlingame, CA, USA) for 90 min, and developed with 
3,3′-diaminobenzidine (DAB) solution (Peroxidase substrate kit, Vector Labs, Burlingame, CA, USA). Sections 
were then washed in distilled water before dehydrating and mounting in DPX (VWR-BDH Dublin, Ireland).
Six different areas covering the entire hippocampus from two sections on anatomically comparable planes/
animal were analysed. 4G8 labeling, divided into major and minor plaques, and AT8 intraneuronal immunore-
activity were blindly assessed.
Protein extracts. Mice were killed by cervical dislocation and hippocampi were quickly dissected from the 
brains. Total tissue homogenates were obtained by homogenizing the hippocampus in a cold lysis buffer with 
protease inhibitors (0.2 M NaCl, 0.1 M HEPES, 10% glycerol, 200 mM NaF, 2 mM Na4P2O7, 5 mM EDTA, 1 mM 
EGTA, 2 mM DTT, 0.5 mM PMSF, 1 mM Na3VO4, 1 mM benzamidine, 10 µg/mL leupeptin, 400 U/mL apro-
tinin). After that, homogenates were centrifuged at 14.000 × g for 20 min at 4 °C and supernatants were aliquoted 
and stored at −80 °C. Total protein concentrations were determined using the Bio-Rad Bradford protein assay 
(Bio-Rad, Hercules, CA, USA).
To obtain the membrane-enriched protein fraction (P2 membrane proteins), a previously described method 
by Dunah et al. was used45. The hippocampi were homogenized in ice-cold Tris-EDTA buffer (10 mM Tris-HCl 
and 5 mM EDTA, pH 7.4), containing 320 mM sucrose and the protease and phosphatase inhibitors previ-
ously described. The tissue homogenate was centrifuged at 700 × g for 10 min. The collected supernatant was 
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centrifuged again at 37.000 × g for 40 min at 4 °C. Finally, the pellet (P2) was resuspended in 10 mM Tris-HCl 
buffer (pH 7.4), containing the enzyme inhibitor mixture described above. In both cases, protein concentration 
was determined (Bradford assay, Bio-Rad, CA, USA) and aliquots were stored at −80 °C until use. For Western 
blot analysis, aliquots of the P2 membrane fraction were solubilized in denaturing conditions by adding 0.1 vol-
umes of 20% SDS and 50% β-mercaptoethanol. The samples were incubated for 5 min at 100 °C and diluted 1:20 
in 50 mM Tris-HCl (pH 9)/0.1% Triton X-100. After a centrifugation step at 37.000 × g for 10 min at 4 °C, the 
supernatant was stored at −80 °C.
For AβPP-derived carboxy-terminal fragments (CTFs) determination, the cortex was homogenized in a buffer 
containing SDS 2%, Tris-HCl (10 mM, pH 7.4), protease inhibitors (Complete Protease Inhibitor Cocktail, Roche) 
and phosphatase inhibitors (0.1 mM Na3VO4, 1 mM NaF). The homogenates were sonicated for 2 min and cen-
trifuged at 100.000 × g for 1 h. Aliquots of the supernatant were frozen at −80 °C and protein concentration was 
determined by the Bradford method using the Bio-Rad protein assay (Bio-Rad, CA, USA).
Immunoblotting. Protein samples from four to six mice per group were mixed with 6X Laemmli sample 
buffer [47% (v/v) glycerol, 0.6 M Dithiothreitol, 12% (w/v) SDS, 0.08 M Tris and bromophenol blue], boiled for 
5 min and resolved onto SDS-polyacrylamide gels46 and transferred to nitrocellulose membrane. The membranes 
were blocked with 5% milk, 0.05% Tween-20 in PBS or tris-buffered saline (TBS) followed by overnight incuba-
tion with the following primary antibodies: rabbit polyclonal anti-Arc (1:1000, Millipore Corporation, Billerica, 
MA, USA), rabbit polyclonal anti-pGluA1 (1:1000, Millipore Corporation, Billerica, MA, USA), rabbit polyclonal 
anti-GluA2/3 (1:1000, Millipore Corporation, Billerica, MA, USA), mouse monoclonal anti-pGSK3β-Tyr216 
(1:1000, BD Transduction Laboratories, Lexington, KT, USA), rabbit polyclonal anti-GSK3β (1:1000, Santa 
Cruz Biotechnology, CA, USA), mouse monoclonal anti-pTau AT8 (1:1000, Thermo Fisher Scientific, Waltham, 
MA USA), mouse monoclonal anti-Tau (1:5000, clone Tau 46, Sigma-Aldrich, St. Luis, MO, USA), rabbit pol-
yclonal anti-MAP-2 (1:1000, Millipore Corporation, Billerica, MA, USA), mouse monoclonal anti-PSD95 
(1:1000, Millipore Corporation, Billerica), mouse monoclonal anti-pCaMK II (1:500, Millipore Corporation, 
Billerica, MA, USA), mouse monoclonal anti-CaMK II (1:1000, Millipore Corporation, Billerica, MA, USA), 
rabbit polyclonal anti-p-Cofilin (1:1000, Cell Signaling Technology, Beverly, MA, USA), rabbit polyclonal 
anti-pAkt Ser473 (1:1000, Cell Signaling Technology, Beverly, MA, USA), rabbit polyclonal anti-VDAC 1 (1:1000, 
Millipore Corporation, Billerica, MA, USA), goat polyclonal anti-HXKI (1:200 Santa Cruz Biotechnology, CA, 
USA), rabbit polyclonal anti-pβ-catenin (1:1000, Cell Signaling Technology, Beverly, MA, USA), rabbit poly-
clonal anti-βcatenin (1:1000, Cell Signaling Technology, MA, USA), rabbit monoclonal anti-Acetyl-Histone 
H3 (Lys9) (C5B11) (1:2000, Cell Signaling Technology, MA, USA), rabbit polyclonal anti-Acetyl-Histone H4 
(1:4000, Millipore Corporation, Billerica, MA, USA), rabbit polyclonal anti-Histone H3 (1:1500, Cell Signaling 
Technology,MA, USA) and mouse monoclonal anti-actin (1:20000, Sigma-Aldrich, St. Louis, MO, USA) in the 
corresponding buffer. Following two washes in PBS/Tween-20 or TBS/Tween-20 and one PBS or TBS alone, 
immunolabelled protein bands were detected by using horseradish peroxidase (HRP)-conjugated anti-rabbit or 
anti-mouse antibody (1:5000, Santa Cruz Biotechnology, CA. USA) following an enhanced chemiluminescence 
system (ECL, GE Healthcare Bioscience, Buckinghamshire, UK), and autoradiographic exposure to Hyperfilm 
ECL (GE Healthcare Bioscience, Buckinghamshire, UK). Quantity One software v.4.6.3 (Bio-Rad, CA, USA) was 
used for quantification.
For the analysis of AβPP-derived CTFs, aliquots of the protein extracts were mixed with XT sample buffer 
plus XT reducing agent (Bio-Rad, CA, USA) or Tricine sample buffer (Bio-Rad, CA, USA) and boiled for 5 min. 
Proteins were separated in a Criterion™ precast Bis-Tris 4–12% gradient precast gel (Bio-Rad, CA, USA) and 
transferred to nitrocellulose membranes. The membranes were blocked with 5% milk, 0.05% Tween-20 in TBS 
followed by overnight incubation with rabbit polyclonal anti-AβPP C-terminal (amino acids 676–695) (1:2000, 
Sigma-Aldrich, St Louis, MO, USA).
BACE-1 Activity Assay. BACE-1 activity was measured using the Fluorometric Beta Secretase Activity 
Assay (Abcam, England, UK) according to manufacturer’s instructions. Cortical tissue (10 mg) was homogenized 
in 12 × (v/w) of ice-cold extraction buffer and cleared by centrifugation. 6 μl of the resulting samples were loaded 
into a white 384-well microplate (Optiplate, Perkin-Elmer) and the fluorogenic substrate was added in the dark. 
The mixture was incubated at 37 °C for one hour in the dark, and the fluorescent signal produced by cleavage of 
the peptide by β-secretase was measured using an Envision 2104 microplate reader (Perkin-Elmer) with 340 nm 
excitation and 495 nm emission wavelengths. Fluorescence was also determined in cells with vehicle, active beta 
secretase in extraction buffer (positive control) and beta secretase inhibitor added to the positive control (negative 
control).
Data analysis and statistical procedures. The data was analysed with SPSS for Windows, version 15.0 
(SPSS, Chicago, IL, USA) and unless otherwise indicated, the data is expressed as means ± standard error of 
the mean (SEM). Normal distribution of data was checked by the Shapiro–Wilks test. In the MWM, latencies 
to find the platform were examined by two-way repeated measures ANOVA test (genotype × trial) to compare 
the cognitive status in WT, WTM, Tg2576 and Tg2576M. Likewise, the spatial memory and the biochemical data 
was examined also by a two-way ANOVA test (treatment × trial) followed by post-hoc Tukey’s analysis. When 
interaction between factors was significant, single effects were analysed by one-way ANOVA followed by post-hoc 
Tukey’s test. When no significant interaction between factors was found, main effects were analysed. Student’s 
t-test was used in case two groups were compared.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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Ethical approval. All animal care and experimental procedures were in accordance with European and 
Spanish regulations (86/609/CEE; RD1201/2005) and were approved by the Ethical Committee of the University 
of Navarra (number. 018/05).
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